טוען...
ARID1A alterations and their clinical significance in cholangiocarcinoma
BACKGROUND: ARID1A is a member of the SWI/SNF chromatin remodeling complex. It functions as a tumor suppressor and several therapeutic targets in ARID1A-mutated cancers are currently under development, including EZH2. A synthetic lethal relationship between ARID1A and EZH2 has been revealed in sever...
שמור ב:
| הוצא לאור ב: | PeerJ |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
PeerJ Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7719290/ https://ncbi.nlm.nih.gov/pubmed/33344089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.10464 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|